Catalyst Pharmaceuticals
CPRX
#3987
Rank
ยฃ2.17 B
Marketcap
ยฃ17.66
Share price
1.95%
Change (1 day)
3.86%
Change (1 year)

Revenue for Catalyst Pharmaceuticals (CPRX)

Revenue in 2025 (TTM): ยฃ0.43 Billion

According to Catalyst Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is ยฃ0.43 Billion. In 2024 the company made a revenue of ยฃ0.39 Billion an increase over the revenue in the year 2023 that were of ยฃ0.31 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Catalyst Pharmaceuticals from 2009 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) ยฃ0.43 B12.18%
2024 ยฃ0.39 B25.37%
2023 ยฃ0.31 B76.53%
2022 ยฃ0.17 B69.7%
2021 ยฃ0.10 B19.43%
2020 ยฃ87.35 M11.97%
2019 ยฃ78.01 M19706.76%
2018 ยฃ0.39 M
2017 N/A
2016 N/A
2015 N/A
2014 N/A
2013 N/A
2012 N/A
2011 N/A-100%
2010 ยฃ0.31 M
2009 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
BioMarin Pharmaceutical
BMRN
ยฃ2.32 B 435.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
ยฃ1.81 B 317.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
ยฃ69.17 B 15,837.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
ยฃ86.82 M-80.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ47.13 B 10,758.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
ยฃ32.91 B 7,482.72%๐Ÿ‡บ๐Ÿ‡ธ USA